The importance of fetuin-A in vascular calcification in children with chronic kidney disease

Irena Makulska1, Maria Szczepańska2, Dorota Drożdż3

  • 1Department of Pediatric Nephrology, Faculty of Medicine, Wroclaw Medical University, Poland.

Insights

Children with chronic kidney disease (CKD) have lower fetuin-A levels, linked to vascular calcification risk factors. Lower fetuin-A may help identify those at risk for vascular disease.

Area of Science:

  • Pediatric Nephrology
  • Cardiovascular Health in CKD
  • Biochemistry of Calcification

Background:

  • Arterial stiffness significantly impacts cardiovascular health in pediatric chronic kidney disease (CKD).
  • Reduced levels of soft tissue calcification inhibitors contribute to vascular calcification in children with CKD.

Purpose of the Study:

  • To investigate the role of fetuin-A in vascular wall hardening in pediatric CKD.
  • To assess serum fetuin-A levels in relation to renal function, dialysis type, and vascular calcification markers.

Main Methods:

  • A cross-sectional study involving 20 children on peritoneal dialysis (PD), 20 on hemodialysis (HD), 36 on conservative treatment, and 26 healthy controls.
  • Measurement of serum fetuin-A, clinical, and biochemical parameters in all participants.

Main Results:

  • Children on hemodialysis (HD) exhibited significantly lower fetuin-A concentrations compared to PD, conservative, and control groups.
  • In pediatric CKD patients, fetuin-A negatively correlated with dialysis vintage, pulse wave velocity/height (PWV/ht), phosphate, calcium-phosphate product (CaxP), and vitamin D3 doses.
  • Across the entire study population, fetuin-A showed negative correlations with blood pressure (BP), PWV/ht, intact parathyroid hormone (iPTH), high-sensitivity C-reactive protein (hsCRP), and cholesterol.

Conclusions:

  • Decreased fetuin-A concentrations in pediatric CKD are associated with established vascular calcification risk factors.
  • Serum fetuin-A may serve as a valuable marker for identifying vascular disease risk in children with CKD.
Abstract

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
740
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
667
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
479
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
400
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.6K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
4.6K